Search the Newsreel

Is IAMGOLD (TSX:IMG) Still Cheap After Its Strong Q2 Update?

IAMGOLD (TSX:IMG) stock has seen a significant multi-year return, yet analysis suggests it remains undervalued based on discounted cash flow (DCF) and P/E ratio metrics. Despite a strong Q2 update and share price reaction, the company's intrinsic value estimates indicate a notable discount to …

IAMGOLD (TSX:IMG) Is Up 28.8% After Strong Q2, Big Buybacks And Board Refresh – What’s Changed

In the second quarter of 2026, IAMGOLD Corporation reported higher sales of US$856.9 million and net income of US$230.5 million year over year, completed a share repurchase of 28,000,000 shares for CA$510.4 million since December 2025, and earlier appointed veteran mining executive Catherine McLeod-Seltzer …

63,219 Shares in Qiagen N.V. $QGEN Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company recently acquired 63,219 shares of Qiagen N.V. (NYSE:QGEN) worth approximately $2.52 million. This purchase is part of broader institutional investment, with various firms like Boston Partners, Norges Bank, and Price T Rowe Associates also holding significant stakes, bringing total …

Cardio Diagnostics Holdings Inc (CDIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Iamgold (NYSE:IAG) Announces Earnings Results

Niagen Bioscience (NAGE) Gains Fresh Momentum, Is The Stock Still Cheap?

Does Niagen Bioscience's (NAGE) Walmart NAD+ Push Redefine Its Healthy‑Aging Brand Narrative?

In early August 2026, Niagen Bioscience Inc. reported slightly lower quarterly sales and net income year on year, while also expanding access to its Tru Niagen® healthy‑aging NAD+ supplement via Walmart.com, initially offering 300 mg bottles in 30‑ and 90‑count formats. A new peer‑reviewed …

Diageo plc Stock 12‑Month Price Target Raised to $104.35, Implies 12% Upside

The average 12-month price target for Diageo plc stock has increased to $104.35 from $103.59, based on estimates from 20 analysts. This updated target suggests a potential upside of approximately 12% from its August 6 closing price. The consensus rating from 23 analysts remains …

Iamgold Q2 Earnings Call Highlights

Key Points Interested in Iamgold Corporation? Here are five stocks we like better. IAMGOLD remains on track for 2026 production guidance of 720,000–820,000 ounces after producing 188,100 attributable ounces in Q2 and 371,700 ounces in the first half. Strong results generated $445.1 million in …

DIAGEO PLC To Go Ex-Dividend On October 15th, 2026 With 0.6 USD Dividend Per Share

DIAGEO PLC is set to go ex-dividend on October 15th, 2026. The company plans to distribute a dividend of 0.6 USD per share to its shareholders. This announcement provides key information for investors regarding the upcoming dividend payment.

Co-Diagnostics Submits Co-Dx PCR Flu A/B & RSV Test for FDA Clearance

Co-Diagnostics has submitted its Co-Dx PCR Flu A/B & RSV multiplex respiratory test for FDA clearance, including a dual 510(k) premarket notification and a CLIA Waiver by Application. This submission is backed by extensive clinical studies involving over 1,400 patients and an analytical program …

Qiagen N.V. (NYSE: QGEN) Q2 2026 profit, $496.7M synthetic buyback and cash flows

QIAGEN N.V. (NYSE: QGEN) reported Q2 2026 net sales of $535.04 million and net income of $103.401 million, with diluted EPS of $0.50. The company executed a $496.7 million synthetic share repurchase in January 2026, reducing outstanding shares by 5.0%, and approved a $0.35 …

Iamgold (NYSE:IAG) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen has downgraded Iamgold (NYSE:IAG) to a "Hold" rating, moving it from a "Buy." Despite this, the broader analyst consensus for Iamgold remains a "Moderate Buy" with an average price target of $19.00. The company reported quarterly EPS of $0.42, matching estimates, …

IAMGOLD Corporation (NYSE: IAG) lifts Q2 2026 cash, cuts debt and buys back shares

IAMGOLD Corporation announced strong Q2 2026 results, reporting increased revenues, net earnings, and adjusted EBITDA, driven by higher gold prices and production. The company strengthened its balance sheet by fully repaying its credit facility, repurchasing 8.6 million shares for $147.9 million, and increasing liquidity …

Quest Diagnostics Incorporated (QDI.F) Stock Price, News, Quote & History

Carriage Services Q2 Earnings Call Highlights

Key Points Interested in Carriage Services, Inc.? Here are five stocks we like better. Second-quarter results improved despite lower funeral volumes: Revenue rose 0.8% to $102.9 million, while adjusted EBITDA increased 3.1% to $33.3 million and adjusted EPS climbed 5.4% to $0.78. Pricing gains, …

Cardio Diagnostics (NASDAQ: CDIO) Q2 2026 shows $5.6M cash and equity funding

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) reported a Q2 2026 net loss of $1.5 million on revenues of $5,360, with cash reserves of $5.6 million. The company continues to fund operations primarily through equity, having raised $3.7 million from at-the-market share sales in 2026, …

Cardio Diagnostics Holdings, Inc. 2026: Revenue $5.36K, EPS ($0.51) — 10-Q Summary

Cardio Diagnostics Holdings, Inc. reported nominal revenue of $5.36K and a diluted loss per share of ($0.51) for the 2026 quarter, reflecting its early commercialization stage and ongoing investments. The company is shifting its go-to-market strategy to non-reimbursement channels and has made progress with …

Quest Diagnostics Inc (DGX) Stock News Today

This article from TradingKey provides a news page for Quest Diagnostics Inc (DGX) stock. It includes current stock performance metrics like price, market cap, and P/E ratio. The page indicates that more news will be coming soon regarding DGX stock.

Qiagen N.V. Stock 12‑Month Price Target Raised to $44.52, Implies 7% Upside

Qiagen N.V.'s average price target has been increased from $43.87 to $44.52 by 17 analysts, suggesting a 7% potential upside based on its closing price. The consensus rating remains a "Buy" from 22 covering analysts. Investors can explore more price target data and analyst …

Iamgold Corp (IAG) (Q2 2026) Earnings Call Highlights: Record Cash Flow and Strategic Expansion ...

This article first appeared on GuruFocus. Release Date: August 07, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Iamgold Corp (NYSE:IAG) produced 188,100 ounces of gold in Q2 2026, bringing year-to-date production to …

Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)

This article is a 6-K filing by Qiagen NV, which is a report for a foreign private issuer. These reports are typically related to financial reporting and other significant company updates that are required by regulatory bodies.

Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN

Quantinno Capital Management LP significantly reduced its stake in Qiagen N.V. by 40.6% in the first quarter, now holding 132,392 shares valued at approximately $5.3 million. Despite this, Qiagen's recent quarterly earnings exceeded expectations, with EPS of $0.62 and revenue of $535 million, and …

PTA-CMS: QIAGEN N.V.: Release of a capital market information

QIAGEN N.V. has filed its Form 6-K Report of Foreign Private Issuer for the quarterly period ended June 30, 2026, with the United States Securities and Exchange Commission (SEC). The document is now accessible on QIAGEN's website. This release provides important capital market information …

QIAGEN N.V. (NYSE: QGEN) tops Q2 EPS outlook and reaffirms 2026 targets

QIAGEN N.V. exceeded its Q2 2026 EPS outlook with adjusted diluted EPS of $0.62, against an outlook of at least $0.60 CER, and reaffirmed its full-year 2026 guidance for net sales growth of about 1-2% CER and adjusted diluted EPS of at least $2.43 …

Diageo PLC (DEO) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Insight Molecular Diagnostics Inc. (7OC0.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Insight Molecular Diagnostics Inc. (7OC0.MU). It lists several instances where analysts from Lake Street and Needham have maintained a "Buy" rating for the company's stock between February 2026 and April 2025. The current stock …

Lucid Diagnostics Inc (LUCD) Stock News Today

This page provides an overview of Lucid Diagnostics Inc (LUCD) stock news, including current trading information and a note that more news is coming soon. The stock is currently trading at 0.953 USD, down 0.05%, with a market cap of 124.88M. The article is …

Carriage Services (CSV) Stock Sinks As Debt Fears Eclipse Steady Margins

Carriage Services (CSV) stock recently dropped significantly, largely due to investor concerns over the company's debt levels, specifically its 4.0x bank leverage. This fear overshadowed an otherwise steady Q2 2026 earnings report, which showed slight increases in revenue and net income, improved adjusted EBITDA …

Carriage Services, Inc. Stock 12‑Month Price Target Cut to $58, Implies 40% Upside

The average 12-month price target for Carriage Services, Inc. (CSV) stock has been reduced from $60 to $58 by five analysts, with forecasts ranging from $50 to $65 per share. This new target suggests a potential upside of approximately 40% from its August 5 …

The Bull Case For Quest Diagnostics (DGX) Could Change Following Raised Guidance And New Self-Collection Services

Vijaya Diagnostic Centre distributes ₹51.8 lakh from fractional share sales

A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09

This article provides a quick look at today's analyst ratings for Qiagen NV (QGEN.US), forecasting a target price between $45.50 and $46.09. It highlights the general sentiment and price targets from various financial institutions.

Carriage Services Inc (CSV) (Q2 2026) Earnings Call Highlights: Strategic Pricing Power Offsets Volume Decline, July Signals Recovery

Carriage Services Inc (CSV) reported a 3.1% increase in adjusted consolidated EBITDA in Q2 2026, reaching $33.3 million, despite a 3.5% decline in comparable funeral volume, primarily due to strong pricing power and cost discipline. The company's financial revenue grew 14% year-over-year, and management …

CIMB Niaga and Ajaib Collaborate to Integrate Banking and Investment Services

Diageo climbs Friday, outperforms market

Diageo PLC (DGE) shares increased by 3.32% to £17.90 on Friday, outperforming the FTSE 100 Index. The rise occurred on an overall positive trading day for the stock market, with the FTSE 100 gaining 0.31%. Despite the Friday climb, Diageo PLC closed 16.43% below …